World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01504568
Date of registration: 03/01/2012
Prospective Registration: No
Primary sponsor: University of Arkansas
Public title: The Use of Prophylactic Antibiotics in Isolated Blowout Fractures
Scientific title: The Use of Prophylactic Antibiotics in Isolated Blowout Fractures
Date of first enrolment: January 2012
Target sample size: 0
Recruitment status: Withdrawn
URL:  http://clinicaltrials.gov/show/NCT01504568
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention  
Phase:  N/A
Countries of recruitment
United States
Contacts
Name:     John Pemberton, D.O.
Address: 
Telephone:
Email:
Affiliation:  University of Arkansas
Name:     Bradley Thuro, M.D.
Address: 
Telephone:
Email:
Affiliation:  University of Arkansas
Name:     Christopher Westfall, M.D.
Address: 
Telephone:
Email:
Affiliation:  University of Arkansas
Key inclusion & exclusion criteria

Inclusion Criteria:

- Isolated orbital blow out fracture in patients between the ages 5 to 99 years old

Exclusion Criteria:

- Involvement of the orbital rim in the floor fracture requiring the use of antibiotics

- Involvement of the orbital rim in the floor fracture

- Radiographic evidence of occlusion of the maxillary sinus ostium

- Determined need for surgical intervention or prior use of synthetic implanted
material in or around the involved maxillary sinus

- Any symptoms of sinonasal disease in the preceding 3 month for any reason

- Any use of oral or IV antibiotics in the preceding 3 month for any reason

- Documented allergy to penicillin or amoxicillin prohibiting its use

- Any currently immunosuppressed state, including actively treated autoimmune disease;
use of steroids, immunomodulatory medication, or chemotherapy within the last year;
diagnosis of active cancer within the last year



Age minimum: 5 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Orbital Fractures
Orbital Cellulitis
Intervention(s)
Other: Treatment
Primary Outcome(s)
Orbital Cellulitis [Time Frame: Two weeks]
Secondary Outcome(s)
Secondary ID(s)
134357
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history